ABBV vs. COST: AbbVie vs. Costco Wholesale Stock Comparison
How do AbbVie (ABBV) and Costco Wholesale (COST) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Costco Wholesale (COST) belongs to Consumer Staples (Consumer Staples Distribution & Retail) — their GICS classifications point to very different parts of the market.
| Profile Item | ABBV | COST |
|---|---|---|
| Name | AbbVie Inc. | Costco Wholesale Corp |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Consumer Staples |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences | Consumer Staples Distribution & Retail |
| GICS Industry | Biotechnology | Consumer Staples Distribution & Retail |
| GICS Sub-Industry | Biotechnology | Consumer Staples Merchandise Retail |
| Market Capitalization | 514.92 billion USD | 466.86 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | January 2, 2013 | July 9, 1986 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABBV | COST |
|---|---|---|
| Total Return (1Y) | 37.33% | 14.87% |
| Total Return (3Y, Annualized) | 32.74% | 24.84% |
| Total Return (5Y, Annualized) | 24.73% | 16.92% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ABBV | COST |
|---|---|---|
| Volatility (1Y, Annualized) | 25.65% | 20.30% |
| Beta (5Y) | 0.21 | 0.84 |
| Max Drawdown (5Y) | -21.92% | -31.40% |
| Avg. Volume (3M) | 4.76M | 2.15M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABBV | COST |
|---|---|---|
| Sharpe Ratio (1Y) | 1.29 | 0.52 |
| Sortino Ratio (1Y) | 2.02 | 0.77 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: Costco Wholesale (COST) earns 28.40% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
--
- Max
- 109.18%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
- ABBV
- --
COST
Consumer Staples Distribution & Retail industry group
28.40%
- Max
- 33.48%
- COST
- 28.40%
- Q3
- 22.31%
- Median
- 15.57%
- Q1
- 7.66%
- Min
- -2.27%
Net Margin (TTM)
AbbVie (ABBV) at 15.67% retains a top-quartile share of revenue as profit, ahead of Costco Wholesale (COST) at 3.04%, which keeps about the industry-typical share.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
15.67%
- Max
- 18.05%
- ABBV
- 15.67%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
COST
Consumer Staples Distribution & Retail industry group
3.04%
- Max
- 5.45%
- Q3
- 3.42%
- COST
- 3.04%
- Median
- 2.44%
- Q1
- 1.86%
- Min
- -0.06%
Operating Margin (TTM)
AbbVie (ABBV) at 39.59% operates in the top operating margin quartile, ahead of Costco Wholesale (COST) at 3.79%, which runs around its industry’s norm.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
39.59%
- Max
- 83.12%
- ABBV
- 39.59%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
COST
Consumer Staples Distribution & Retail industry group
3.79%
- Max
- 6.81%
- Q3
- 5.49%
- Median
- 3.84%
- COST
- 3.79%
- Q1
- 2.00%
- Min
- 0.97%
Profitability Metrics
| Metric | ABBV | COST |
|---|---|---|
| ROE (TTM) | -- | 28.40% |
| ROA (TTM) | 10.74% | 8.66% |
| Net Margin (TTM) | 15.67% | 3.04% |
| Operating Margin (TTM) | 39.59% | 3.79% |
| Gross Margin (TTM) | 73.72% | 12.77% |
Growth
Revenue Growth
Both AbbVie (ABBV) at 8.57% and Costco Wholesale (COST) at 10.14% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: AbbVie (ABBV) reports EPS growth of -0.84%, ranked against its industry; Costco Wholesale (COST) has no EPS growth figure this period.
Growth Metrics
| Metric | ABBV | COST |
|---|---|---|
| Revenue Growth (YoY) | 8.57% | 10.14% |
| Revenue Growth (3Y CAGR) | 1.75% | 7.76% |
| EPS Growth (YoY) | -0.84% | -- |
| EPS Growth (3Y CAGR) | -29.03% | -- |
Financial Strength
Current Ratio (MRQ)
Costco Wholesale (COST) at 1.06 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.87
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- ABBV
- 0.87
- Min
- 0.10
COST
Consumer Staples Distribution & Retail industry group
1.06
- Max
- 2.04
- Q3
- 1.45
- Median
- 1.17
- COST
- 1.06
- Q1
- 1.00
- Min
- 0.69
Debt / Equity (MRQ)
Only one side’s leverage can be read here: Costco Wholesale (COST) carries debt-to-equity ratio of 0.28 against its industry range, while AbbVie (ABBV) reports no figure this period.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
--
- Max
- 1.42
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
- ABBV
- --
COST
Consumer Staples Distribution & Retail industry group
0.28
- Max
- 2.59
- Q3
- 1.83
- Median
- 1.24
- Q1
- 0.63
- COST
- 0.28
- Min
- 0.01
Financial Strength Metrics
| Metric | ABBV | COST |
|---|---|---|
| Current Ratio (MRQ) | 0.87 | 1.06 |
| Debt / Equity (MRQ) | -- | 0.28 |
| Net Debt / EBITDA | 2.21 | -0.78 |
Dividends
Dividend Yield (TTM)
Costco Wholesale (COST) at 0.52% pays an industry-typical yield; AbbVie (ABBV) at 2.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
2.40%
- ABBV
- 2.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
COST
Consumer Staples Distribution & Retail industry group
0.52%
- Max
- 2.90%
- Q3
- 1.72%
- COST
- 0.52%
- Median
- 0.43%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Costco Wholesale (COST) reports 26.69%, ranking against industry peers normally.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
117.35%
- ABBV
- 117.35%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
COST
Consumer Staples Distribution & Retail industry group
26.69%
- Max
- 57.98%
- Q3
- 30.05%
- COST
- 26.69%
- Median
- 11.72%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABBV | COST |
|---|---|---|
| Dividend Yield (TTM) | 2.40% | 0.52% |
| Dividend Payout Ratio (TTM) | 117.35% | 26.69% |
Valuation
P/E Ratio (TTM)
Both AbbVie (ABBV) at 50.05 and Costco Wholesale (COST) at 50.75 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
50.05
- Max
- 85.34
- ABBV
- 50.05
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
COST
Consumer Staples Distribution & Retail industry group
50.75
- COST
- 50.75
- Max
- 50.75
- Q3
- 33.64
- Median
- 22.19
- Q1
- 16.09
- Min
- 9.28
P/S Ratio (TTM)
AbbVie (ABBV) at 7.80 is priced about in line with its industry on P/S ratio, while Costco Wholesale (COST) at 1.54 sits in the pricier quartile — COST costs more per dollar of sales.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
7.80
- Max
- 58.18
- Q3
- 25.77
- ABBV
- 7.80
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
COST
Consumer Staples Distribution & Retail industry group
1.54
- COST
- 1.54
- Max
- 1.54
- Q3
- 0.81
- Median
- 0.47
- Q1
- 0.26
- Min
- 0.02
P/B Ratio (MRQ)
AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Costco Wholesale (COST) reports 13.04, ranking against industry peers normally.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
-112.34
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
- ABBV
- -112.34
COST
Consumer Staples Distribution & Retail industry group
13.04
- COST
- 13.04
- Max
- 10.15
- Q3
- 6.27
- Median
- 3.70
- Q1
- 1.85
- Min
- 0.93
Valuation Metrics
| Metric | ABBV | COST |
|---|---|---|
| P/E Ratio (TTM) | 50.05 | 50.75 |
| P/S Ratio (TTM) | 7.80 | 1.54 |
| P/B Ratio (MRQ) | -112.34 | 13.04 |
| Free Cash Flow Yield (TTM) | 3.44% | 1.45% |